Role of Diffusion-Weighted Magnetic Resonance Imaging in Predicting Sensitivity to Chemoradiotherapy in Muscle-Invasive Bladder Cancer-Reference-Cited by-同舟云学术

Role of Diffusion-Weighted Magnetic Resonance Imaging in Predicting Sensitivity to Chemoradiotherapy in Muscle-Invasive Bladder Cancer

Published:2012-05 Issue:1 Volume:83 Page:e21-e27
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Yoshida Soichiro,Koga Fumitaka,Kobayashi Shuichiro,Ishii Chikako,Tanaka Hiroshi,Tanaka Hajime,Komai Yoshinobu,Saito Kazutaka,Masuda Hitoshi,Fujii Yasuhisa,Kawakami Satoru,Kihara Kazunori

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference20 articles.

1. 15-year survival rates after transurethral resection and radiochemotherapy or radiation in bladder cancer treatment;Krause;Anticancer Res,2011

2. Trimodality treatment and selective organ preservation for bladder cancer;Rodel;J Clin Oncol,2006

3. Overview of bladder cancer trials in the Radiation Therapy Oncology Group;Shipley;Cancer,2003

4. Current status of radiation therapy for bladder cancer;Sandler;Expert Rev Anticancer Ther,2010

5. Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: An intent-to-treat survival analysis;Koga;Urology,2008

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiparametric MRI in Era of Artificial Intelligence for Bladder Cancer Therapies;Cancers;2023-11-18

2. The assessment of pathological response to neoadjuvant chemotherapy in muscle-invasive bladder cancer patients with DCE-MRI and DWI: a systematic review and meta-analysis;The British Journal of Radiology;2023-10

3. Accurate, repeatable, and geometrically precise diffusion-weighted imaging on a 0.35 T magnetic resonance imaging-guided linear accelerator;Physics and Imaging in Radiation Oncology;2023-10

4. Selective multimodal bladder-sparing therapy for muscle-invasive bladder cancer: the present and the future;Expert Review of Anticancer Therapy;2023-09-27

5. Fluoxetine inactivates STAT3/NF-κB signaling and promotes sensitivity to cisplatin in bladder cancer;Biomedicine & Pharmacotherapy;2023-08